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Abstract Conformational changes in cystine disulfide bridges of 
bovine serum albumin during acid-induced isomerization (N -»F 
and F -> E transitions) have been studied with Raman spectros-
copy. In an X-ray crystallographic study of human serum 
albumin, Carter and Ho reported that all disulfide bridges of the 
albumin molecule are in the gauche-gauche-gauche conformation 
[1]. On the other hand, the solution structure of bovine serum 
albumin examined by Raman spectroscopy differs from its 
crystal structure in the conformation of some of the disulfide 
bridges. Two Raman bands were detected at 520 and 505 cm * in 
the disulfide stretching mode region, suggesting that the 17 
disulfide bridges in the N-form of bovine serum albumin solution 
take both the gauche-gauche-gauche and gauche-gauche-trans 
conformations. The ratio of the peak intensities at 520 and 505 
cm_1 (I505/I520) is increased from 1.6 to 2.1 and from 2.1 to 6.3 
on going from the N- to the F-form and from the F- to the E-
form, respectively, indicating that the gauche-gauche-trans 
conformation of the disulfide bridges is converted to a gauche-
gauche-gauche one which is the most energetically stable form 
during the acid-induced isomerization. However, small amounts 
of gauche-gauche-trans conformation still remain even in the 
E-form. 
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1. Introduction 
Serum albumin is the most abundant protein in mammalian 
plasma and has been the subject of many investigations be-
cause of its easy isolation in large quantities, its high stability 
and its solubility. Albumin is the principal protein contribut-
ing to the colloid osmotic pressure of the blood and also the 
transport protein for numerous endogenous and exogenous 
compounds [2]. This molecule, having a molecular mass of 
66 kDa, consists of a single polypeptide chain containing 
about 580 amino acids [2]. Bovine serum albumin (BSA) 
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undergoes remarkable reversible changes in conformation, 
usually under non-physiological conditions. In the pH range 
from 4.40 to 2.80, the reversible conformational changes occur 
in two steps [3]. The first step, between pH 4.40 and pH 3.75 
(0.10 M KC1), is called the N—>F transition, while the second 
step, between pH 3.60 and pH 2.80 (0.10 M KC1), is called the 
F->E transition [3]. Physicochemical techniques such as in-
trinsic viscosities [4], effective radii obtained by moving boun-
dary electrophoresis [5,6], helical contents [7-10], tryptophyl 
fluorescence spectra [11], rotational correlation times of la-
beled spin-probe [12] etc., showed the two-step changes cor-
responding to N - > F and F->E transitions (acid-induced 
isomerization). The physiological significance of these 
transitions, especially that of the N—>F transition, may be 
suggested by the conservation of this transition among vari-
ous species (human, bovine, rat [13] and turkey [1]). 
Three-dimensional protein structure is influenced and stabi-
lized to a great extent by cystine disulfide bridges. Serum 
albumin has one cysteinyl residue at position 34 (Cys-34) 
and 17 disulfide bridges per molecule [2]. The unique feature 
of albumin structure is the 17 disulfide bridges pattern. A 
feature to this pattern is the presence of two neighboring 
cysteinyl residues (disulfide pairing) throughout the sequence 
and these disulfide pairings are located between helical seg-
ments [1,2]. 
Raman spectroscopy has been employed extensively to 
probe the conformation of disulfide bridges in proteins and 
peptides because the frequency of an S-S stretching mode of 
the disulfide bridge is sensitive to its conformation [14]. Ram-
an bands at ~510, ~525 and ~540 cm - 1 due to the S-S 
stretching mode can be ascribed to gauche-gauche-gauche 
(ggg), gauche-gauche-trans (ggt or tgg) and trans-gauche- trans 
(tgt) configurations of the CfJ-S-S'-CP' disulfide bridges, re-
spectively [15,16]. Raman spectra of BSA have already been 
investigated in some detail by several research groups [17-21], 
and it was reported that only a single Raman band was ob-
served near 510 cm - 1 in the S-S stretching band region. Based 
upon this observation it was concluded that the 17 disulfide 
bridge conformation of BSA can only be a ggg conformer 
[20,21]. In addition, recent X-ray crystallographic studies of 
human serum albumin (HSA) [1] are undoubtedly in good 
agreement with the conclusion from Raman spectroscopy 
[20,21]. 
In the present study, the conformation of BSA in solutions 
has been investigated by Raman spectroscopy in order to ex-
plore whether the conformation of 17 disulfide bridges is in-
deed only a ggg conformer and whether conformational 
changes occur during acid-induced isomerization. 
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2. Materials and methods 
Crystallized BSA (lot Y74806) was purchased from Armour Phar-
maceutical Co. and used without further purification. For pH study, 
BSA solution had an ionic strength of 0.10 M NaCl. BSA solution 
was filtered through a Milex HV filter (0.45 urn) to minimize Tyndall 
scattering on recording the Raman spectra. All other chemicals em-
ployed were of reagent grade. 
The Raman measurements were carried out using a Jasco R-800 
laser Raman spectrometer at ambient temperature. The 514.5 nm line 
from an argon ion laser (stabilite 2017, Spectra Physics Co.) was used 
for excitation, and the laser power at the sample position was 150^00 
mW. An average of four or eight scans was collected for each spec-
trum. Data acquisition was performed with a Hewlett Packard 9122 
personal computer. The obtained spectra in the 550-470 cm-1 region 
were subjected to numerical curve fitting (Grams/386; Galactic Ind. 
Co.); the band shapes were approximated by a Gaussian function. 
The baseline was approximated by a straight line between two points 
at 550 and 480 cm-1, chosen at both sides of the band envelope. 
Concentration of BSA was determined with a Hitachi 320 spectro-
photometer assuming E (1%, 1 cm) at 279 nm to be 6.67. Concen-
tration was 2.50% for the series of pH experiments. The pH measure-
ments were made with a Hitachi-Horiba F-7SS, equipped with an 
expanded scale, using a Radiometer GK-2401C combined electrode. 
3. Results and discussion 
Fig. 1 shows the Raman spectrum of a BSA solution 
(2.50%, 0.10 M NaCl) at pH 5.0 (the N-form). The observed 
frequencies of Raman bands are almost identical to those 
reported previously [17-21], and assignments for the bands 
have already been made in detail [19,20]. Serum albumin 
has one cysteine residue and 17 disulfide bridges, and they 
play important roles in the intramolecular sulfhydryl-disulfide 
exchange reaction (N-A isomerization, molecular aging of 
BSA) [3,10,22-24]. To obtain qualitative information about 
these disulfide bridges conformation is a matter of great im-
portance. Of note in Fig. 1 is that cystine disulfide stretching 
vibrations of BSA generate a strong Raman band at 508 cm - 1 
with a weak shoulder at 517 cm- 1 . A relative intensity of the 
two bands at 517 and 508 cm - 1 may be estimated by curve 
fitting of the experimental band profile in the 550^70 cm - 1 
region. 
Fig. 2 shows results for the curve fitting in the region of 
550^70 cm"1 for the Raman spectra of the N- (pH 5.29), F-
(pH 3.78) and E-forms (pH 2.60) of BSA. After the curve 
fitting of the band profile to the minimum number of Gaus-
sian components, we were able to identify two disulfide 
stretching bands at ~520 and ~505 cm- 1 . In the previously 
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Fig. 1. A Raman spectrum (2000-470 cm"1) of BSA (2.50%) in 0.10 
M NaCl at pH 5.0 (the N-form). 
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Fig. 2. Curve fitting for the cystine disulfide band profile in the re-
gion of 550-470 cm-1 of the Raman spectra of BSA (2.50%) in 
0.10 M NaCl. A: N-form (pH 5.29). B: F-form (pH 3.78). C: E-
form (pH 2.60). 
reported papers, only a single Raman frequency was reported 
in the 550-500 cm - 1 region, and it was concluded that the 17 
disulfide bridges of BSA can only assume a ggg conformer 
[20,21]. As described above, the Raman spectrum of BSA 
solution (0.10 M NaCl) at pH 5.0 (Fig. 1) and their Raman 
frequencies are similar to those reported previously [17-21]. 
However, on the high-frequency side of the 505 cm - 1 band, 
we successfully observed the weak feature near 520 cm- 1 , 
assignable to a disulfide stretching mode of a ggt (or tgg) 
conformer by the curve fitting for the experimental band pro-
file. Thus, it may be concluded that the 17 disulfide bridges in 
the N-form of the BSA solution structure assume mainly the 
ggg conformer but also take the ggt (or tgg) conformation. 
The ratio of peak intensities at 520 and 505 cm - 1 (I505/I520) m 
the N-form (pH 5.29) of BSA is 1.6, indicating that about 10 
out of 17 disulfide bridges of the molecule take ggg, the re-
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maining ones take the ggt (or tgg) conformer, and no tgt 
conformer is presented in the N-form of BSA. Of course, it 
is rather difficult to estimate the exact numbers of ggg and ggt 
(or tgg) conformers in the protein because the Raman scatter-
ing intensity of the S-S stretching band of each conformer 
may be different and the results of the curve fitting have 
some ambiguity. With the decrease in pH of the BSA solution, 
the value for I505/I520 increased from 1.6 to 2.1 and from 2.1 
to 6.3, as shown in Fig. 2A,B,C. It is therefore very likely that 
the ggt conformation of the disulfide bridges in the N-form is 
converted to the ggg one during acid-induced isomerization. 
According to the X-ray crystallographic data [1], the albu-
min molecule is composed of three homologous domains (I, II 
and III) and each domain is the product of two subdomains, 
which are predominantly helical. About 67% of the albumin 
structure is helical, ~ 23% is in an extended chain conforma-
tion, and ~ 10%o is in turn [1]. Therefore, the albumin mole-
cule is predominantly oc-helix-rich protein as examined by 
various spectroscopic [7-10] and X-ray crystallographic [1] 
methods. 
As already mentioned, the 17 disulfide bridge pattern is 
characterized by the presence of two neighboring cysteinyl 
residues (disulfide pairing) throughout the sequence and these 
disulfide pairings are located between the helical segments 
(subdomains). This property not only makes the albumin mol-
ecule very compact but is also responsible for its stability. 
From the home-made three-dimensional helical model (Maru-
zen Co., Japan) of BSA based on X-ray crystallographic data 
[1] and the complete amino acid sequence [2], quite surpris-
ingly, one can find that six disulfide bridges (Cys-53-Cys-62 
and Cys-167-Cys-176 in domain I; Cys-244-Cys-252 and Cys-
359-Cys-368 in domain II; Cys-436-Cys-447 and Cys-557-Cys-
566 in domain III) are located in the very short turns between 
the helical subdomains. Furthermore, disulfide pairings such 
as Cys-168 next to Cys-167 in domain I, Cys-245 next to Cys-
244, Cys-360 next to Cys-359 in domain II and Cys-437 next 
to Cys-436, Cys-558 next to Cys-557 in domain III are located 
within these short turns in each domain. These peculiar disul-
fide bridges restrict the potential packing arrangement be-
tween the subdomains. Based on this consideration, together 
with the present Raman result, it may be concluded that 
about six disulfide bridges, which are noted above, adopt 
the energetically unfavorable ggt (or tgg) conformation in 
the N-form of BSA. The N -> F transition can be interpreted 
as the isomerization of domains I and II, without loss of helix 
content, and the unfolding of domain III in the cooperative 
process [25-28]. Therefore, the conformation of two disulfide 
bridges in domain III may convert from ggt (or tgg) to ggg 
conformers during the N -»F transition. Finally, the value for 
I505/I520 in the E-form of BSA becomes 6.3, indicating that 
most disulfide bridges in the E-form of the BSA solution 
structure are in the ggg conformation, the most energetically 
stable disulfide conformation. However, small amounts of ggt 
(or tgg) conformation still remain, even in the E-form (pH 
2.60). 
According to the result obtained with circular dichroism 
(CD)-resolved secondary structure of BSA previously reported 
by us [8], the helical contents of the N-, F- and E-forms of 
BSA solution are 72, 62 and 52%>, respectively. It follows that 
BSA molecules still have a highly helical content even in the 
E-form. A Raman band of BSA, which serves as an indicator 
for the oc-helix structure, is identified at 940 cm - 1 (the skeletal 
C-C stretching vibration). The strong intensity of this marker 
is indicative of a high a-helix content [14]. The intensity de-
crease in this band during acid-induced isomerization is con-
sistent with the CD results [8] (data not shown). 
From the sets of the present Raman results and CD-re-
solved secondary structural changes of BSA [8], one can spec-
ulate that acid-induced isomerization, i.e. the N - > F and 
F -> E transitions, corresponds to the loss of the intradomain 
helices associated with the sequential domain-domain and/or 
subdomain-subdomain dissociations, and some of the 17 di-
sulfide bridges undergo a conformational change from ggt to 
ggg conformers during acid-induced isomerization. 
Recently, recombinant serum albumin has been achieved by 
gene expression in yeast [29-31], in order to serve as a serum 
replacement product. Seventeen disulfide bridges of serum al-
bumin undoubtedly stabilize the structure of this molecule 
very effectively and its conformation is unusually stable under 
a variety of harsh conditions. 
What is needed now is knowledge of the three-dimensional 
structure of the recombinant serum albumin such as the di-
sulfide bridge conformation, by various physicochemical and 
X-ray crystallographic techniques. 
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